Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 5Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 81Carcinoma, Non-Small-Cell Lung 73Prostatic Neoplasms 72Neoplasms 56Multiple Myeloma 49Lung Neoplasms 45Colorectal Neoplasms 40Melanoma 33Neoplasm Metastasis 31Pancreatic Neoplasms 30Lymphoma, Non-Hodgkin 30Leukemia, Myeloid, Acute 29Lymphoma 28Squamous Cell Carcinoma of Head and Neck 27Ovarian Neoplasms 26Carcinoma, Renal Cell 26Leukemia, Lymphocytic, Chronic, B-Cell 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Endometrial Neoplasms 22Stomach Neoplasms 21Carcinoma, Hepatocellular 21Uterine Cervical Neoplasms 20Sarcoma 20Glioma 20Urinary Bladder Neoplasms 19Recurrence 18Rectal Neoplasms 18Hematologic Neoplasms 18Lymphoma, Mantle-Cell 17Head and Neck Neoplasms 17

Interventions

niraparib 1Rosuvastatin Calcium 1Prednisone 1Pioglitazone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Prostatic Neoplasms, Castration-Resistant × 30 days × Clear all
NCT02592317 2026-06-05

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Aragon Pharmaceuticals, Inc.

Phase 1 Active not recruiting
23 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT03748641 2026-06-05

MAGNITUDE

Janssen Research & Development, LLC

Phase 3 Active not recruiting
765 enrolled 16 charts 1 FDA
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡